| K-number | K252357 |
| Device name | Glucose2 |
| Applicant | Abbott Ireland |
| Product code | CFR |
| Device class | Class II |
| Decision date | Oct 24, 2025 |
| Decision | Substantially Equivalent |
| Regulation | 862.1345 |
The FDA summary PDF for this submission is not available in machine-readable form — common for older clearances. View on FDA's site →
View the full FDA submission: accessdata.fda.gov